ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: A. Chetta (Parma, Pr, Italy), V. Cottin (Lyon, France)

Dynamic changes of monocyte human leukocyte antigen-DR and T cell subsets in sepsis J. Xu (Beijing, China)
Effects of idebenone on pulmonary morbidity in Duchenne muscular dystrophy (DMD) O. Mayer (United States of America)
Efficacy of Idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): Comparison of analysis methods O. Mayer (United States of America)
Exploring Efficacy and Safety of Oral Pirfenidone for Progressive, non-IPF Lung Fibrosis (RELIEF-Study) J. Behr (München, Germany)
Randomized controlled trial of abituzumab in systemic sclerosis-associated interstitial lung disease D. Khanna (Ann Arbor, United States of America)
The Effect of MK-7264, a P2X3 antagonist, on Cough Reflex Sensitivity in a Randomized Crossover Trial of Healthy and Chronic Cough Subjects A. Morice (Cottingham, United Kingdom)
Inhibition of P2X3 by MK-7264 reduces 24-hour cough frequency in a randomized, controlled, Phase 2b clinical trial J. Smith (Manchester, United Kingdom)